Calidi Biotherapeutics, Inc. Long-Term Debt, Maturity, Remainder of Fiscal Year
Calidi Biotherapeutics, Inc. (CLDI) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $375.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2025-08-08
- 2025-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $375.00K.
- 2025-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $750.00K.
- 2024-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $750.00K.
- 2023-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $2.25M.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2025-06-30 | $375.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $750.00K 10-Q · filed 2025-05-14 |
| 2024-03-31 | $750.00K 10-Q · filed 2024-05-14 |
| 2023-09-30 | $2.25M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |